IMAX Corporation (NYSE:IMAX – Get Free Report) saw unusually large options trading activity on Thursday. Stock traders acquired 3,458 call options on the company. This is an increase of 241% compared to the average daily volume of 1,014 call options.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of IMAX from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Wedbush restated an “outperform” rating and issued a $46.00 target price on shares of IMAX in a research note on Thursday, April 23rd. JPMorgan Chase & Co. reduced their price target on IMAX from $48.00 to $47.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Roth Capital reiterated a “buy” rating on shares of IMAX in a report on Thursday. Finally, Benchmark reissued a “buy” rating on shares of IMAX in a research report on Monday, June 22nd. Nine investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $47.30.
Read Our Latest Research Report on IMAX
Insider Transactions at IMAX
Institutional Investors Weigh In On IMAX
Institutional investors have recently added to or reduced their stakes in the stock. Orbis Allan Gray Ltd grew its position in shares of IMAX by 31.7% in the second quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after purchasing an additional 1,230,267 shares during the period. Westfield Capital Management Co. LP lifted its position in IMAX by 44.6% during the fourth quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock worth $86,726,000 after buying an additional 723,861 shares in the last quarter. Marsico Capital Management LLC purchased a new position in shares of IMAX during the 4th quarter worth $18,149,000. Balyasny Asset Management L.P. acquired a new position in shares of IMAX during the 2nd quarter valued at about $12,568,000. Finally, Nuveen LLC grew its holdings in shares of IMAX by 253.0% in the fourth quarter. Nuveen LLC now owns 507,377 shares of the company’s stock valued at $18,753,000 after purchasing an additional 363,658 shares during the period. Institutional investors and hedge funds own 93.51% of the company’s stock.
Key Stories Impacting IMAX
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX beat second-quarter expectations, reporting EPS of $0.43 versus the $0.28 consensus and revenue of $102.84 million versus $94.69 million expected. The company also posted 12.2% year-over-year revenue growth, reinforcing momentum in its core business. Article Title
- Positive Sentiment: Management highlighted The Odyssey as a potentially “transformational” event for IMAX, with the film’s debut already generating unusually strong IMAX ticket sales and broad media attention around the company’s 70mm and premium-large-format exposure. Article Title
- Positive Sentiment: Heavy call-option activity suggests traders are positioning for more upside, with call volume jumping well above normal levels. That kind of activity often signals bullish sentiment around a stock’s near-term outlook.
- Neutral Sentiment: Several articles focused on the record-breaking opening weekend for The Odyssey, including strong IMAX ticket participation and premium-screen demand. These stories are supportive for the brand, but they are more indirect than the earnings results in terms of immediate stock impact.
- Neutral Sentiment: Rosenblatt Securities reiterated a “Buy” rating, which adds a favorable analyst backdrop, though it is not as market-moving as the quarterly beat.
IMAX Stock Up 9.4%
Shares of NYSE:IMAX traded up $3.68 during midday trading on Thursday, reaching $42.98. The company’s stock had a trading volume of 1,581,046 shares, compared to its average volume of 1,122,476. The stock has a fifty day moving average of $39.60 and a 200 day moving average of $37.94. The firm has a market capitalization of $2.36 billion, a PE ratio of 66.85, a P/E/G ratio of 1.39 and a beta of 0.37. IMAX has a twelve month low of $24.20 and a twelve month high of $45.52.
IMAX (NYSE:IMAX – Get Free Report) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.15. IMAX had a return on equity of 13.61% and a net margin of 9.08%.The business had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $94.69 million. During the same quarter in the previous year, the firm posted $0.26 EPS. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. Sell-side analysts anticipate that IMAX will post 1.3 earnings per share for the current fiscal year.
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Articles
- Five stocks we like better than IMAX
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
- Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
- Forging Profits: The Executive Order Sparking Aluminum
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
